The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Intramuscular Injector-Global Market Insights and Sales Trends 2025

Intramuscular Injector-Global Market Insights and Sales Trends 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1822889

No of Pages : 111

Ask Your Query
Synopsis
Intramuscular injector is an injecting device used to delivering medications deep into the muscles. At present, intramuscular injectors are used in modern medicine to enable quick absorption of medication in the bloodstream. Generally, these injectors are used to deliver vaccines and drugs. In addition, these are highly preferred to other drug delivery routes for quick treatment, as muscle tissues have higher blood supply as compared to the tissues present under the skin and muscles are capable of holding high volume of medication.
The global Intramuscular Injector market size is expected to reach US$ 13930 million by 2029, growing at a CAGR of 6.7% from 2023 to 2029. The market is mainly driven by the significant applications of Intramuscular Injector in various end use industries. The expanding demands from the Hospitals, Clinics, Ambulatory Surgery Centers and Others, are propelling Intramuscular Injector market. Pre-fillable Injection System, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Fillable Needle-free Injectors segment is estimated at % CAGR for the next seven-year period.
The global intramuscular injectors market is driven by growth in prevalence of chronic diseases that require medications through muscles, rise in demand for biosimilars and vaccination, and increased demand for drug delivery due to its advantages.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Intramuscular Injector, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Intramuscular Injector market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Intramuscular Injector market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Intramuscular Injector sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Intramuscular Injector covered in this report include Antares Pharma, Endo International Plc, Bioject Medical Technologies, PharmaJetMedical International Technology, National Medical Products, Valeritas, European Pharma Group, PenJet Corporation and Becton, etc.
The global Intramuscular Injector market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Antares Pharma
Endo International Plc
Bioject Medical Technologies
PharmaJetMedical International Technology
National Medical Products
Valeritas
European Pharma Group
PenJet Corporation
Becton
Dickinson
Injex Pharma AG
Crossject SA
Solace Biotech
Sanify Healthcare Private Limited
Novosanis
Vata
Kaleo
Global Intramuscular Injector market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Intramuscular Injector market, Segment by Type:
Pre-fillable Injection System
Fillable Needle-free Injectors
Global Intramuscular Injector market, by Application
Hospitals
Clinics
Ambulatory Surgery Centers
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Intramuscular Injector manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Intramuscular Injector in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index
1 Intramuscular Injector Market Overview
1.1 Intramuscular Injector Product Overview
1.2 Intramuscular Injector Market Segment by Type
1.2.1 Pre-fillable Injection System
1.2.2 Fillable Needle-free Injectors
1.3 Global Intramuscular Injector Market Size by Type
1.3.1 Global Intramuscular Injector Market Size Overview by Type (2018-2029)
1.3.2 Global Intramuscular Injector Historic Market Size Review by Type (2018-2023)
1.3.3 Global Intramuscular Injector Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Intramuscular Injector Sales Breakdown by Type (2018-2023)
1.4.2 Europe Intramuscular Injector Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Intramuscular Injector Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Intramuscular Injector Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Intramuscular Injector Sales Breakdown by Type (2018-2023)
2 Global Intramuscular Injector Market Competition by Company
2.1 Global Top Players by Intramuscular Injector Sales (2018-2023)
2.2 Global Top Players by Intramuscular Injector Revenue (2018-2023)
2.3 Global Top Players by Intramuscular Injector Price (2018-2023)
2.4 Global Top Manufacturers Intramuscular Injector Manufacturing Base Distribution, Sales Area, Product Type
2.5 Intramuscular Injector Market Competitive Situation and Trends
2.5.1 Intramuscular Injector Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Intramuscular Injector Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Intramuscular Injector as of 2022)
2.7 Date of Key Manufacturers Enter into Intramuscular Injector Market
2.8 Key Manufacturers Intramuscular Injector Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Intramuscular Injector Status and Outlook by Region
3.1 Global Intramuscular Injector Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Intramuscular Injector Historic Market Size by Region
3.2.1 Global Intramuscular Injector Sales in Volume by Region (2018-2023)
3.2.2 Global Intramuscular Injector Sales in Value by Region (2018-2023)
3.2.3 Global Intramuscular Injector Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Intramuscular Injector Forecasted Market Size by Region
3.3.1 Global Intramuscular Injector Sales in Volume by Region (2024-2029)
3.3.2 Global Intramuscular Injector Sales in Value by Region (2024-2029)
3.3.3 Global Intramuscular Injector Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Intramuscular Injector by Application
4.1 Intramuscular Injector Market Segment by Application
4.1.1 Hospitals
4.1.2 Clinics
4.1.3 Ambulatory Surgery Centers
4.1.4 Others
4.2 Global Intramuscular Injector Market Size by Application
4.2.1 Global Intramuscular Injector Market Size Overview by Application (2018-2029)
4.2.2 Global Intramuscular Injector Historic Market Size Review by Application (2018-2023)
4.2.3 Global Intramuscular Injector Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Intramuscular Injector Sales Breakdown by Application (2018-2023)
4.3.2 Europe Intramuscular Injector Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Intramuscular Injector Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Intramuscular Injector Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Intramuscular Injector Sales Breakdown by Application (2018-2023)
5 North America Intramuscular Injector by Country
5.1 North America Intramuscular Injector Historic Market Size by Country
5.1.1 North America Intramuscular Injector Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Intramuscular Injector Sales in Volume by Country (2018-2023)
5.1.3 North America Intramuscular Injector Sales in Value by Country (2018-2023)
5.2 North America Intramuscular Injector Forecasted Market Size by Country
5.2.1 North America Intramuscular Injector Sales in Volume by Country (2024-2029)
5.2.2 North America Intramuscular Injector Sales in Value by Country (2024-2029)
6 Europe Intramuscular Injector by Country
6.1 Europe Intramuscular Injector Historic Market Size by Country
6.1.1 Europe Intramuscular Injector Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Intramuscular Injector Sales in Volume by Country (2018-2023)
6.1.3 Europe Intramuscular Injector Sales in Value by Country (2018-2023)
6.2 Europe Intramuscular Injector Forecasted Market Size by Country
6.2.1 Europe Intramuscular Injector Sales in Volume by Country (2024-2029)
6.2.2 Europe Intramuscular Injector Sales in Value by Country (2024-2029)
7 Asia-Pacific Intramuscular Injector by Region
7.1 Asia-Pacific Intramuscular Injector Historic Market Size by Region
7.1.1 Asia-Pacific Intramuscular Injector Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Intramuscular Injector Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Intramuscular Injector Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Intramuscular Injector Forecasted Market Size by Region
7.2.1 Asia-Pacific Intramuscular Injector Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Intramuscular Injector Sales in Value by Region (2024-2029)
8 Latin America Intramuscular Injector by Country
8.1 Latin America Intramuscular Injector Historic Market Size by Country
8.1.1 Latin America Intramuscular Injector Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Intramuscular Injector Sales in Volume by Country (2018-2023)
8.1.3 Latin America Intramuscular Injector Sales in Value by Country (2018-2023)
8.2 Latin America Intramuscular Injector Forecasted Market Size by Country
8.2.1 Latin America Intramuscular Injector Sales in Volume by Country (2024-2029)
8.2.2 Latin America Intramuscular Injector Sales in Value by Country (2024-2029)
9 Middle East and Africa Intramuscular Injector by Country
9.1 Middle East and Africa Intramuscular Injector Historic Market Size by Country
9.1.1 Middle East and Africa Intramuscular Injector Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Intramuscular Injector Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Intramuscular Injector Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Intramuscular Injector Forecasted Market Size by Country
9.2.1 Middle East and Africa Intramuscular Injector Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Intramuscular Injector Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Antares Pharma
10.1.1 Antares Pharma Company Information
10.1.2 Antares Pharma Introduction and Business Overview
10.1.3 Antares Pharma Intramuscular Injector Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Antares Pharma Intramuscular Injector Products Offered
10.1.5 Antares Pharma Recent Development
10.2 Endo International Plc
10.2.1 Endo International Plc Company Information
10.2.2 Endo International Plc Introduction and Business Overview
10.2.3 Endo International Plc Intramuscular Injector Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Endo International Plc Intramuscular Injector Products Offered
10.2.5 Endo International Plc Recent Development
10.3 Bioject Medical Technologies
10.3.1 Bioject Medical Technologies Company Information
10.3.2 Bioject Medical Technologies Introduction and Business Overview
10.3.3 Bioject Medical Technologies Intramuscular Injector Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Bioject Medical Technologies Intramuscular Injector Products Offered
10.3.5 Bioject Medical Technologies Recent Development
10.4 PharmaJetMedical International Technology
10.4.1 PharmaJetMedical International Technology Company Information
10.4.2 PharmaJetMedical International Technology Introduction and Business Overview
10.4.3 PharmaJetMedical International Technology Intramuscular Injector Sales, Revenue and Gross Margin (2018-2023)
10.4.4 PharmaJetMedical International Technology Intramuscular Injector Products Offered
10.4.5 PharmaJetMedical International Technology Recent Development
10.5 National Medical Products
10.5.1 National Medical Products Company Information
10.5.2 National Medical Products Introduction and Business Overview
10.5.3 National Medical Products Intramuscular Injector Sales, Revenue and Gross Margin (2018-2023)
10.5.4 National Medical Products Intramuscular Injector Products Offered
10.5.5 National Medical Products Recent Development
10.6 Valeritas
10.6.1 Valeritas Company Information
10.6.2 Valeritas Introduction and Business Overview
10.6.3 Valeritas Intramuscular Injector Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Valeritas Intramuscular Injector Products Offered
10.6.5 Valeritas Recent Development
10.7 European Pharma Group
10.7.1 European Pharma Group Company Information
10.7.2 European Pharma Group Introduction and Business Overview
10.7.3 European Pharma Group Intramuscular Injector Sales, Revenue and Gross Margin (2018-2023)
10.7.4 European Pharma Group Intramuscular Injector Products Offered
10.7.5 European Pharma Group Recent Development
10.8 PenJet Corporation
10.8.1 PenJet Corporation Company Information
10.8.2 PenJet Corporation Introduction and Business Overview
10.8.3 PenJet Corporation Intramuscular Injector Sales, Revenue and Gross Margin (2018-2023)
10.8.4 PenJet Corporation Intramuscular Injector Products Offered
10.8.5 PenJet Corporation Recent Development
10.9 Becton
10.9.1 Becton Company Information
10.9.2 Becton Introduction and Business Overview
10.9.3 Becton Intramuscular Injector Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Becton Intramuscular Injector Products Offered
10.9.5 Becton Recent Development
10.10 Dickinson
10.10.1 Dickinson Company Information
10.10.2 Dickinson Introduction and Business Overview
10.10.3 Dickinson Intramuscular Injector Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Dickinson Intramuscular Injector Products Offered
10.10.5 Dickinson Recent Development
10.11 Injex Pharma AG
10.11.1 Injex Pharma AG Company Information
10.11.2 Injex Pharma AG Introduction and Business Overview
10.11.3 Injex Pharma AG Intramuscular Injector Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Injex Pharma AG Intramuscular Injector Products Offered
10.11.5 Injex Pharma AG Recent Development
10.12 Crossject SA
10.12.1 Crossject SA Company Information
10.12.2 Crossject SA Introduction and Business Overview
10.12.3 Crossject SA Intramuscular Injector Sales, Revenue and Gross Margin (2018-2023)
10.12.4 Crossject SA Intramuscular Injector Products Offered
10.12.5 Crossject SA Recent Development
10.13 Solace Biotech
10.13.1 Solace Biotech Company Information
10.13.2 Solace Biotech Introduction and Business Overview
10.13.3 Solace Biotech Intramuscular Injector Sales, Revenue and Gross Margin (2018-2023)
10.13.4 Solace Biotech Intramuscular Injector Products Offered
10.13.5 Solace Biotech Recent Development
10.14 Sanify Healthcare Private Limited
10.14.1 Sanify Healthcare Private Limited Company Information
10.14.2 Sanify Healthcare Private Limited Introduction and Business Overview
10.14.3 Sanify Healthcare Private Limited Intramuscular Injector Sales, Revenue and Gross Margin (2018-2023)
10.14.4 Sanify Healthcare Private Limited Intramuscular Injector Products Offered
10.14.5 Sanify Healthcare Private Limited Recent Development
10.15 Novosanis
10.15.1 Novosanis Company Information
10.15.2 Novosanis Introduction and Business Overview
10.15.3 Novosanis Intramuscular Injector Sales, Revenue and Gross Margin (2018-2023)
10.15.4 Novosanis Intramuscular Injector Products Offered
10.15.5 Novosanis Recent Development
10.16 Vata
10.16.1 Vata Company Information
10.16.2 Vata Introduction and Business Overview
10.16.3 Vata Intramuscular Injector Sales, Revenue and Gross Margin (2018-2023)
10.16.4 Vata Intramuscular Injector Products Offered
10.16.5 Vata Recent Development
10.17 Kaleo
10.17.1 Kaleo Company Information
10.17.2 Kaleo Introduction and Business Overview
10.17.3 Kaleo Intramuscular Injector Sales, Revenue and Gross Margin (2018-2023)
10.17.4 Kaleo Intramuscular Injector Products Offered
10.17.5 Kaleo Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Intramuscular Injector Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Intramuscular Injector Industrial Chain Analysis
11.4 Intramuscular Injector Market Dynamics
11.4.1 Intramuscular Injector Industry Trends
11.4.2 Intramuscular Injector Market Drivers
11.4.3 Intramuscular Injector Market Challenges
11.4.4 Intramuscular Injector Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Intramuscular Injector Distributors
12.3 Intramuscular Injector Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock